AMPA antagonists: do they hold more promise for clinical stroke trials than NMDA antagonists?
The cytoprotective effects of MK-801 and NBQX, selective N-methyl-D-aspartate (NMDA) and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor antagonists, respectively, were compared both singularly and in combination in models of transient severe forebrain and transient focal c...
主要な著者: | Buchan, A, Lesiuk, H, Barnes, K, Li, H, Huang, Z, Smith, K, Xue, D |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
1993
|
類似資料
PSYCHOPHARMACOLOGICAL PROFILE OF THE NMDA RECEPTOR ANTAGONIST MK-801
著者:: Iversen, S, 等
出版事項: (1987)
著者:: Iversen, S, 等
出版事項: (1987)
類似資料
-
Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction.
著者:: Xue, D, 等
出版事項: (1994) -
DELAYED TREATMENT WITH AMPA BUT NOT NMDA GLUTAMATE ANTAGONISTS REDUCES NEOCORTICAL INFARCTION
著者:: Xue, D, 等
出版事項: (1992) -
POSTISCHEMIC TREATMENT WITH AMPA, BUT NOT NMDA, ANTAGONISTS PREVENTS CA1 NEURONAL INJURY
著者:: Li, H, 等
出版事項: (1992) -
The rise and fall of NMDA antagonists for ischemic stroke.
著者:: Hoyte, L, 等
出版事項: (2004) -
NMDA antagonists: their role in neuroprotection.
著者:: Small, D, 等
出版事項: (1997)